ORLANDO, Fla.–(BUSINESS WIRE)–Retina Consultants of America continues growth by adding 13 physicians with Florida Retina Institute to its nationwide network.
Author: Business Wire
Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Eric Keller, J.D. and Hou…
Choroideremia Drug Pipeline Insights Report 2022 Featuring Spark Therapeutics, Molecular Therapeutics, Curative Biotechnology, & Ray Therapeutics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Choroideremia – Pipeline Insight, 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Choroideremia pipeline landscape. …
Alcon Reports Third Quarter 2022 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter 2022 Results
Worldwide Artificial Eye Industry to 2027 – Rise in Medical Tourism for Eye Implantation is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Eye Market Research Report by Product, Technology, End-use, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Artificial Eye…
Global Optical Coherence Tomography for Ophthalmology Market to 2027 – Featuring Abbott Laboratories, Agfa-Gevaert, Canon Medical Systems and Carl Zeiss Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Coherence Tomography for Ophthalmology Market Research Report by Product, Type, Technology, End user, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.co…
Boundless Bio to Participate at Two Upcoming Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its Chief Executive Officer, Za…
RestoringVision Launches New Program Serving Indigenous Populations
SAN FRANCISCO–(BUSINESS WIRE)–RestoringVision, supported by generous funding from long-time corporate donor, National Vision, Inc., is launching a new program this Native American Heritage Month to serve indigenous populations in the United States. T…
Worldwide Ophthalmic Sutures Industry to 2027 – Adoption of Minimally Invasive Surgeries and Absorbable Sutures is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Sutures Market Research Report by Type, Absorption Capacity, Application, End-user, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. T…
University of Denver Study Shows King-Devick Test in association with Mayo Clinic is an Accurate Tool for Detecting, Tracking and Measuring the Severity of Long COVID
CHICAGO–(BUSINESS WIRE)–Study Shows King-Devick Test in association with Mayo Clinic is an Accurate Tool for Detecting, Tracking and Measuring the Severity of Long COVID
EyeSouth Partners Affiliates with University Retina and Macula Associates, Representing the Network’s 34th affiliation and Third in Illinois
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with University Retina and Macula Associates (“URMA”). The affiliation represents EyeSouth’s third in the state of Ill…
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates
EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including lead asset NPM-119 for the treatment of patients with type 2 di…
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2022 and provides a business update. Financial results for the first nine months of 202…
Harrow Announces Third Quarter 2022 Financial Results
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (NASDAQ: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced results for the third qua…
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (the “Company”) (NYSE American: NBY) announces that today, following approval from the Company’s stockholders obtained at the Company’s November 10, 2022 special stockholders’ meeting,…
India Contact Lenses Market 2023-2028: Rising Disposable Income Has Enhanced the Demand for Premium Contact Lenses in the Indian Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Contact Lenses Market 2023-2028” report has been added to ResearchAndMarkets.com’s offering. MARKET OUTLOOK The contact lenses market in India is expected to display growth with CAGRs of 10.58% by revenue and a CAGR …
Heru Continues to Revolutionize Vision Care, Surpassing Clinical Milestone of 100,000 Eyes Examined
MIAMI–(BUSINESS WIRE)–Today, Heru Inc. announced that it has passed the clinical milestone of over 100,000 patient eyes that have been examined using its wearable technology since the company’s commercial launch a little over a year ago. “We are thri…
Global Dry Eye Treatment Devices Market Report 2022: An Upsurge in The Number of Eye Care Facilities Drives Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Treatment Devices Market Size, Share & Industry Trends Analysis Report by Technology, End-user, Regional Outlook and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The G…
Luminopia, Inc. Announces Oversubscribed Seed Extension Financing Round
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Luminopia, Inc. today announced an oversubscribed $5.7M seed extension financing round.
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update